Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

William H Chappell

Showing results (1-10 of 33) with videos related to

Pageof 4
Sort By:
Cell Cycle (Georgetown, Tex.)|February 8, 2008
Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cellsJohn T Lee, Linda S Steelman, William H Chappell, et al.
Journal of Virology|May 23, 2014
Productive replication of human papillomavirus 31 requires DNA repair factor Nbs1Daniel C Anacker, Dipendra Gautam, Kenric A Gillespie, et al.
Journal of Virology|December 25, 2015
Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31William H Chappell, Dipendra Gautam, Suzan T Ok, et al.
Oncotarget|September 2, 2011
Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cellsJackson R Taylor, Brian D Lehmann, William H Chappell, et al.
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Distinct roles for p107 and p130 in Rb-independent cellular senescenceBrian D Lehmann, Adam M Brooks, Matthew S Paine, et al.
Cell Cycle (Georgetown, Tex.)|August 13, 2005
Increased protein expression of the PTEN tumor suppressor in the presence of constitutively active Notch-1William H Chappell, Thomas D Green, Justin D Spengeman, et al.
Cell Cycle (Georgetown, Tex.)|March 14, 2007
A dominant role for p53-dependent cellular senescence in radiosensitization of human prostate cancer cellsBrian D Lehmann, James A McCubrey, Holly S Jefferson, et al.
Cell Cycle (Georgetown, Tex.)|November 29, 2012
p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3William H Chappell, Brian D Lehmann, David M Terrian, et al.
Cell Cycle (Georgetown, Tex.)|January 11, 2014
Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cellsMelissa Sokolosky, William H Chappell, Kristin Stadelman, et al.
Cell Cycle (Georgetown, Tex.)|July 3, 2008
Targeting prostate cancer based on signal transduction and cell cycle pathwaysJohn T Lee, Brian D Lehmann, David M Terrian, et al.
Pageof 4

Showing results (1-10 of 33) with videos related to

Sort By:
Pageof 4
Cell Cycle (Georgetown, Tex.)|February 8, 2008
Akt inactivates ERK causing decreased response to chemotherapeutic drugs in advanced CaP cellsJohn T Lee, Linda S Steelman, William H Chappell, et al.
Journal of Virology|May 23, 2014
Productive replication of human papillomavirus 31 requires DNA repair factor Nbs1Daniel C Anacker, Dipendra Gautam, Kenric A Gillespie, et al.
Journal of Virology|December 25, 2015
Homologous Recombination Repair Factors Rad51 and BRCA1 Are Necessary for Productive Replication of Human Papillomavirus 31William H Chappell, Dipendra Gautam, Suzan T Ok, et al.
Oncotarget|September 2, 2011
Cooperative effects of Akt-1 and Raf-1 on the induction of cellular senescence in doxorubicin or tamoxifen treated breast cancer cellsJackson R Taylor, Brian D Lehmann, William H Chappell, et al.
Cell Cycle (Georgetown, Tex.)|April 18, 2008
Distinct roles for p107 and p130 in Rb-independent cellular senescenceBrian D Lehmann, Adam M Brooks, Matthew S Paine, et al.
Cell Cycle (Georgetown, Tex.)|August 13, 2005
Increased protein expression of the PTEN tumor suppressor in the presence of constitutively active Notch-1William H Chappell, Thomas D Green, Justin D Spengeman, et al.
Cell Cycle (Georgetown, Tex.)|March 14, 2007
A dominant role for p53-dependent cellular senescence in radiosensitization of human prostate cancer cellsBrian D Lehmann, James A McCubrey, Holly S Jefferson, et al.
Cell Cycle (Georgetown, Tex.)|November 29, 2012
p53 expression controls prostate cancer sensitivity to chemotherapy and the MDM2 inhibitor Nutlin-3William H Chappell, Brian D Lehmann, David M Terrian, et al.
Cell Cycle (Georgetown, Tex.)|January 11, 2014
Inhibition of GSK-3β activity can result in drug and hormonal resistance and alter sensitivity to targeted therapy in MCF-7 breast cancer cellsMelissa Sokolosky, William H Chappell, Kristin Stadelman, et al.
Cell Cycle (Georgetown, Tex.)|July 3, 2008
Targeting prostate cancer based on signal transduction and cell cycle pathwaysJohn T Lee, Brian D Lehmann, David M Terrian, et al.
Pageof 4